home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Alliant Health Solutions, Inc.

SHARESHARESHARE
Alliant Health Solutions is a nonprofit organization driven to make health care better in the United States by improving quality of care, increasing the value of health care, and promoting prevention and treatment for chronic illnesses. Our family of companies provide professional services to state, federal and private partners, supporting the effective administration of health care programs and improvement initiatives. Alliant has three primary lines of service offerings that leverage evidenced-based methods, data and technology, and clinical expertise
SHARESHARESHARE

RELATED NEWS


Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today announced that it has entered into a definitive securities purchase agreement with various accredited investors and certain members of Imprimis' Board of Directors and senior management, including the CEO, CFO, and Senior Director of Corporate Development, to raise gross proceeds of approximately $9.8 million in a private placement of Units…...
PR NEWSWIRE
READ MORE

The US Food and Drug Administration (FDA) has accepted Glaxo Smith Klines application for Zejula (niraparib) in late stage ovarian cancer with priority review. The company announced that Tesaro, an oncology-focused business acquired by GSK, submitted a supplemental New Drug Application (sNDA) to the governing body, with an expected action date of 24 October 2019. The sNDA supports a potential new indication for the treatment in advanced ovarian, fallopian tube, or primary peritoneal cancer patie...

READ MORE

This month, the world celebrates International Women’s Day—a timely reminder of the millions of women across the globe suffering without adequate maternal care. Women living in poor, rural areas are the most vulnerable. They bear the highest risk of developing childbirth injuries like obstetric fistula, a wrenching consequence of obstructed labor. Fistula renders a woman incontinent, and too often, she becomes a social outcast because of her constant smell....
PHARMA TIMES
READ MORE

After pressing five pharma companies for answers about how executive pay plays into drug pricing decisions, the Interfaith Center on Corporate Responsibility has generated some interest in the issue among the investor community. A group of investors at AbbVie, Amgen, Biogen, Bristol-Myers Squibb and Eli Lilly supported first-year resolutions by the faith-based group requesting annual reports about the link between executive pay incentives and U.S. drug prices. ICCR filed its resolutions after se...
FIERCEPHARMA
READ MORE

In the second big M&A deal of the year following BMS’s acquisition of Celgene, Eli Lilly has announced it will acquire precision cancer medicine specialists Loxo Oncology in a deal worth $8 billion. The acquisition is the largest and latest in a series of transactions by Lilly to broaden its cancer treatment efforts, which include its $1.6 billion purchase of ARMO BioSciences in May last year. Loxo is a biopharmaceutical company focused on targeted medicines for cancers that are unique...

READ MORE

The rate of workforce drug positivity hit a sixteen-year high in 2019, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. Positivity rates in the combined U.S. workforce increased in urine drug tests, climbing to the highest level since 2003 (4.5%) and more than 28% percent higher than the thirty-year low of 3.5 percent recorded between 2010 and 2012. In addition to overall increases in workforce drug ...
PRNEWSWIRE
READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...